Business Description
Transgene SA is a French biotechnology company focused on developing cancer treatments, including therapeutic vaccines and oncolytic viruses. Founded in 1979 and based in Illkirch-Graffenstaden, it operates as a subsidiary of TSGH SAS. The company has several treatments in clinical trials targeting cancers such as ovarian, head and neck, and lung cancer, among others. Transgene works alongside major partners including AstraZeneca, Pfizer, Merck, and Sanofi to advance its pipeline.
